Recent News
Read ArticleDr. Jack Cush reviews regulatory reports, news and novel journal articles - this week focusing on Sjogrens, ILD, Gout and Uveitis.
RA-ILD at Higher Risk for Serious Infection and Death
A prospective, multicenter study from Spain has demonstrated higher rates of mortality and serious infection in rheumatoid arthritis–associated interstitial lung disease (RA-ILD) patients.
https://t.co/cjmcNi0ZqL https://t.co/wUXNWNeyOa
Dr. John Cush @RheumNow ( View Tweet)
Lupus Accelerating Breakthroughs Consortium Partners with FDA
https://t.co/GW7Zy72oIZ https://t.co/AGYY8WDKcK
Dr. John Cush @RheumNow ( View Tweet)
Retrospective study of hand/feet Xrays in early/suspected #RA due to low prevalence of erosions (4.4%) seldom leading to change in Dx (2pts; 0.3%) or prognosis change (0.4%). Seronegative had less erosions; Longer Sxs not assoc w/ erosions https://t.co/YCj04ZlQJq https://t.co/fHf6EvGOyc
Dr. John Cush @RheumNow ( View Tweet)
TNR: Vasculitis Replay
This recap session features highlights from #RNL2024 with lectures on:
Vasculitis & Pregnancy - by Catherine Sims, MD
GPA Management in 2024 - by Anisha Dua, MD, MPH
Treat to Target in Vasculitis - by Philip Seo, MD
https://t.co/KgkNEcKEC3 https://t.co/e3RcTl3FXe
Dr. John Cush @RheumNow ( View Tweet)
SGLT2 Inhibitors Lowers Gout Risks in Type 2 Diabetes
A population-based cohort has demonstrated that sodium-glucose cotransporter-2 inhibitors (SGLT2i) use in gout patients is superior to sulfonylurea therapy in lowering the risk of incident gout and recurrent flares among patients with type 2 diabetes (T2D).
Read Article
BSR Guideline on Management of Sjogren’s Syndrome
Sjögren disease (SD) is the most common of all autoimmune disease, yet little is know of its etiology and there are insufficent interventions for those affected with mucosal or systemic manifestations.
https://t.co/Y8hNoBmBn3 https://t.co/up5motCwkp
Dr. John Cush @RheumNow ( View Tweet)
The lateral foot/ankle anatomy 🥰 https://t.co/yuGt1seUd4
Faraz Sethi @farazzledphysio ( View Tweet)
Did you know the first clinical controlled trials were done on sailors with scurvy? They were randomized to: a quart of cider, HCl, 2 spoons of vinegar, pint of sea water, spicy nutmeg paste w/ water vs. 2 oranges and a lemon. Guess which sailors fared best? #RheumGR @UTSWRheum https://t.co/fAeCeIxZ9e
TheDaoIndex @KDAO2011 ( View Tweet)
AbbVie announced preliminary positive results from phase 3 SELECT-GCA study showing remission in 46% of #GCA pts Rx w/ upadacitinib for 52wks (vs 29% PBO); RCT included a 26-wk steroid taper regimen https://t.co/lqGVHKw3XF https://t.co/EyLuf8QLZA
Dr. John Cush @RheumNow ( View Tweet)
PJP PPx in AAV
@anisha_dua #RNL2024 @RheumNow
919 GPA pts on RTX - only 31% on TMP/SMX
13 pts devel PJP, not on PPx
Overall decreased serious infections (HR 0.5), outpt infections HR 0.7
Adverse effects on TMP/SMX 29.6 vs 13.4
For every serious ifn avoided, 2-3 pts will have AE
Dr. John Cush @RheumNow ( View Tweet)
Metrics Used by Rheumatologists in RA
https://t.co/Pu40jbqhHR https://t.co/jtMm5odrxU
Dr. John Cush @RheumNow ( View Tweet)
Examples of Healthcare ChatBots
https://t.co/aEhcd1W9td https://t.co/h0VxJkF2GE
Dr. John Cush @RheumNow ( View Tweet)
RA-ILD at Higher Risk for Serious Infection and Death
A prospective, multicenter study from Spain has demonstrated higher rates of mortality and serious infection in rheumatoid arthritis–associated interstitial lung disease (RA-ILD) patients.
Read Article
Lupus Accelerating Breakthroughs Consortium Partners with FDA
EurekAlert!
The Lupus Research Alliance (LRA), founder and administrator of the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), announced today at the Consortium’s first anniversary meeting an expanded partnership with the U.S. Food and Drug Administration (FDA) with the inclusion of the Center for Biologics Evaluation and Research (CBER).
Read Article
GPA Management in 2024
https://t.co/ASmIAS4XrT https://t.co/t4AlNInuzG
Dr. John Cush @RheumNow ( View Tweet)
Peripheral dermatomes & key muscles of the most important lumbosacral
nerve roots. However, keep in mind that the muscles also receive contributions from other nerves (e.g., the extensor digitorum longus is innervated mainly by L5, but also from L4 and S1). https://t.co/auXMMddUIh
Dr. OMID BANDARCHI @OBandarchi ( View Tweet)
#peritendinous #ultrasoundguidedinjection with #osteniltendon for Tendinopathy of the #tibialisposterior #tendon #mskus #pocus #pocushub #GElogiqE10r3 https://t.co/8qe1G27tAl
Dr Jörg Dünkel @SportklinikBern ( View Tweet)
ICYMI: Vasculitis Pearls
https://t.co/7z6b0Wj37X https://t.co/PHlOvFG9qQ
Dr. John Cush @RheumNow ( View Tweet)
Biopsy Results in Sjogren's Syndrome Save
A prospective study from the Netherlands analyzed the comparative value of simultaneous labial and parotid salivary gland biopsies performed in patients with sicca complaints and suspected SjD.
https://t.co/meJgf7dI8N https://t.co/zHg6SgiufS
Dr. John Cush @RheumNow ( View Tweet)
FDA has approved a ustekinumab biosimilar (ustekinumab-aekn; AKA Selardsi), made by Teva & Alvotech, for the treatment of moderate to severe plaque psoriasis (PsO) and active psoriatic arthritis (PsA) in both adults and pediatric pts.https://t.co/ZXvFjjH7Qt https://t.co/7FJKxSVAgL
Dr. John Cush @RheumNow ( View Tweet)
From the blog
Over the last few decades, Japanese workers were collapsing dead at their desks or committing suicide due to the high stress stemming from their jobs; Japan coined this phenomenon, “Karoshi.” In 2021, the World Health Organization and International Labour Organization issued a warning: working 55+ hours a week is a serious health hazard and increases the risk for death from heart disease and stroke. But since the pandemic, I see many colleagues working hard at the expense of their health, family life, mental and emotional well-being. I never thought I would be burned out because I had passion for my job.
Read Post
Podcasts
Canary In A Coal Mine (4.19.2024)
Vasculitis Faculty Panel Q&A
Tuesday Night Rheumatology- Vasculitis Mavens
GPA Management In 2024 - Dr. Anisha Dua
Poster Hall
